Please login to the form below

Launch of Global Atrial Fibrillation Patient Portal on World Stroke Day

On World Stroke Day, Blue Latitude Health announced the launch of Sign Against Stroke, a patient and carer centric online portal for people impacted by atrial fibrillation. It was developed by the Sign Against Stroke Task Force to empower patients and their family members.

Working with the Sign Against Stroke (SAS) Task Force, Blue Latitude Health has created a patient-centric portal to provide information on how to manage Atrial Fibrillation (AF) and help prevent AF-related strokes.



We are pleased to announce the launch of Sign Against Stroke, a patient and carer centric website for people impacted by AF, on World Stroke Day. The website includes downloadable materials developed by the Sign Against Stroke Task Force to empower patients and their family members.

The goal of the new SAS site is to successfully inform and educate people on Atrial Fibrillation, AF-related stroke and the treatment options. The ultimate aim is to empower patients in taking an active role in their health care. 

During development, Blue Latitude Health focused on understanding the needs and learning journey of people impacted by AF and stroke, and also their carers from pre-diagnosis to treatment. The design was based on an appreciation of how people approach coming to terms with their condition, from both a rational and emotional perspective. This meant not only looking at the types of content, but how content was written, presented, and structured. This approach resulted in relevant information being introduced to patients and carers through compelling Sign Against Stroke infographics, which aim to explain complex concepts in a visual, easily digestible form.

Learn more about the Sign Against Stroke portal, the Sign Against Stroke Task Force, and the project on the Blue Latitude Health website.


3rd November 2015

Share

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom

Latest content on this profile

Three strategies for managing loss of exclusivity successfully
Consultant, Claire Taylor explains why you should be strategically planning your LOE strategy years in advance.
Blue Latitude Health
What does the future hold for Medical Affairs?
Lori Lush, Head of Fishawack Medical, reveals why she’s driven to tell impactful scientific stories, the benefits of cross-functional collaboration, and the trends she predicts for the next five years.
Blue Latitude Health
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the life sciences industry can do to rebuild trust.
Blue Latitude Health
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and Senior Consultant Craig Moore explore the benefits of using real-world evidence and the common pitfalls life science companies should avoid.
Blue Latitude Health
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of this lost time for patients?
Blue Latitude Health
Unpacking rare diseases in the first edition of Delta magazine
Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization
Blue Latitude Health